6-heptyne-2,5-diamine has been researched along with Cancer of Prostate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bencsik, K; Boldizsár, M; Kálnay, A; Kremmer, T; Mihalik, R; Pályi, I; Turi, G | 1 |
Burke, G; Guinan, P; Levasseur, S; Poleck, T; Shaw, M | 1 |
2 other study(ies) available for 6-heptyne-2,5-diamine and Cancer of Prostate
Article | Year |
---|---|
Effects of methylacetylenic putrescine, an ornithine decarboxylase inhibitor and potential novel anticancer agent, on human and mouse cancer cell lines.
Topics: Alkynes; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Death; Cell Division; Cell Survival; Diamines; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Inhibitory Concentration 50; Leukemia P388; Male; Mice; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Polyamines; Prostatic Neoplasms; Thyroid Neoplasms; Tumor Cells, Cultured | 1999 |
The effects of polyamine antimetabolites on polyamine-responsive casein kinase activity.
Topics: Adenocarcinoma; Adenosylmethionine Decarboxylase; Alkynes; Animals; Antineoplastic Agents; Casein Kinases; Cytosol; Diamines; Eflornithine; Female; Male; Mice; Mitoguazone; Ornithine Decarboxylase Inhibitors; Phosphoproteins; Phosphorylation; Prostatic Neoplasms; Protein Kinases; Rats; Spermine; Thyroid Gland | 1987 |